Search

Arthur Decarlo Phones & Addresses

  • Vestavia, AL
  • Ellicott City, MD
  • 783 Lavender Cir, Ft Lauderdale, FL 33327 (954) 660-0765
  • 1327 Portofino Cir, Sunrise, FL 33326 (954) 660-0765
  • Weston, FL
  • Fallston, MD

Work

Company: Agenta biotechnologies, inc. Sep 2005 Address: Birmingham, Alabama Position: President and cso

Education

Degree: Ph.D. School / High School: University of Alabama at Birmingham 1986 to 1994 Specialities: Biochemistry and Molecular Biology

Skills

Cell Culture • Drug Discovery • Drug Development • Lifesciences • Biotechnology • Molecular Biology • Cell Biology • Biochemistry • Technology Transfer • Genomics • Genetics • Pcr • Healthcare • Infectious Diseases • Science • Immunology • Protein Expression • Clinical Trials • Protein Chemistry • Commercialization • Cancer • Purification • Oncology • Cell • Pharmaceutical Industry • Hplc • Clinical Development • Animal Models • Elisa • Assay Development • Protein Purification • Western Blotting • Pharmacology • Clinical Research • Strategic Planning

Interests

Biologic Drug Development • Biologic Drug Discovery

Industries

Higher Education

Resumes

Resumes

Arthur Decarlo Photo 1

Research Scientist

View page
Location:
Valdosta, GA
Industry:
Higher Education
Work:
Agenta Biotechnologies, Inc. - Birmingham, Alabama since Sep 2005
President and CSO

Nova Southeastern University - Ft. Lauderdale, Florida Jul 2001 - Jun 2005
Assoc. Prof., Dir. Biological Research Dentistry, Chair HPD Research Comm.
Education:
University of Alabama at Birmingham 1986 - 1994
Ph.D., Biochemistry and Molecular Biology
University of Alabama at Birmingham 1988 - 1992
Clinical Certificate, Periodontal Surgery
University of Rochester School of Medicine and Dentistry 1984 - 1985
University of Maryland Baltimore 1980 - 1984
DDS, General Dentistry
University of Maryland College Park 1977 - 1980
B.S., Biology
Washington and Lee University 1976 - 1977
Skills:
Cell Culture
Drug Discovery
Drug Development
Lifesciences
Biotechnology
Molecular Biology
Cell Biology
Biochemistry
Technology Transfer
Genomics
Genetics
Pcr
Healthcare
Infectious Diseases
Science
Immunology
Protein Expression
Clinical Trials
Protein Chemistry
Commercialization
Cancer
Purification
Oncology
Cell
Pharmaceutical Industry
Hplc
Clinical Development
Animal Models
Elisa
Assay Development
Protein Purification
Western Blotting
Pharmacology
Clinical Research
Strategic Planning
Interests:
Biologic Drug Development
Biologic Drug Discovery

Business Records

Name / Title
Company / Classification
Phones & Addresses
Arthur A Decarlo
incorporator
The Birmingham Youth Lacrosse League, Inc
ANY LAWFUL ACTIVITY
Birmingham, AL

Publications

Us Patents

Wound And Cutaneous Injury Healing With A Nucleic Acid Encoding Perlecan

View page
US Patent:
7488719, Feb 10, 2009
Filed:
Nov 27, 2006
Appl. No.:
11/604633
Inventors:
Arthur A. DeCarlo - Weston FL, US
John Whitelock - Sydney, AU
Assignee:
Agenta Biotechnologies, Inc. - Birmingham AL
International Classification:
A01K 63/00
A61K 48/00
US Classification:
514 44, 424 932, 424 9321
Abstract:
A description of a biomolecule named Perlecan which is added internally or topically, or is expressed from exogenously added nucleic acids, as a whole or in part, to a healing wound to improve the success of wound healing is disclosed. Relevant embodiments for this patent technology are described.

Wound And Cutaneous Injury Healing With A Nucleic Acid Encoding A Proteoglycan Polypeptide

View page
US Patent:
7666852, Feb 23, 2010
Filed:
May 14, 2007
Appl. No.:
11/803404
Inventors:
Arthur A. Decarlo - Vestavia Hills AL, US
John Whitelock - Strath Field, AU
April L. Ellis - Pinson AL, US
Assignee:
Agenta Biotechnologies, Inc. - Birmingham AL
International Classification:
A01K 63/00
A61K 48/00
US Classification:
514 44, 424 932, 424 9321
Abstract:
The present disclosure provides nucleic acid constructs encoding one or more polypeptides containing at least one glycosaminoglycan chain, such as, but not limited to, a proteoglycan polypeptide, and methods for delivering to the site of a wound or cutaneous injury at least one nucleic acid construct encoding one or more such polypeptides, such that the expressed polypeptide is glycated by glycosaminoglycan chains through the normal physiological processes of the subject at the site of administration to produce a functional proteoglycan polypeptide for the healing of the wound or other cutaneous injury. The delivered nucleic acid construct is transcribed, translated and post-translationally modified by the addition of glycosaminoglycan chains (referred herein as “decoration” or “glycation”) to produce a decorated polypeptide. The decorated polypeptide is then secreted from the cell in which it was produced to provide treatment of wounds and/or cutaneous injury in the subject and/or prevention of cutaneous injury in a subject.

Perlecan And Growth Factor For Wound And Cutaneous Injury Healing

View page
US Patent:
7772204, Aug 10, 2010
Filed:
Aug 22, 2008
Appl. No.:
12/196992
Inventors:
Arthur A. DeCarlo - Vestavia Hills AL, US
John Whitelock - Sydney, AU
Assignee:
Agenta Biotechnologies, Inc. - Birmingham AL
International Classification:
A61K 31/70
A01N 63/00
US Classification:
514 44, 424450
Abstract:
The present disclosure describes the use of the heparan sulfate proteoglycan perlecan as treatment for the improvement of wound healing and/or cutaneous injury.

Detecting Genetic Risk For Periodontal Disease

View page
US Patent:
20070003947, Jan 4, 2007
Filed:
Jan 13, 2006
Appl. No.:
11/331572
Inventors:
Arthur DeCarlo - Vestavia Hills AL, US
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435006000, 435091200
Abstract:
A method and kit for the identification of a user's genotypes associated with increased risk for developing periodontal disease are disclosed. The kit includes non-invasive DNA sample collecting means, and disclosed are means for determining certain genotypes which are then compared to those of controls with known periodontal disease status to determine a user's relative risk for developing periodontal disease.

Composition, Preparation, And Use Of Dense Chitosan Membrane Materials

View page
US Patent:
20130164311, Jun 27, 2013
Filed:
Dec 22, 2011
Appl. No.:
13/334388
Inventors:
Arthur A. DeCarlo - Vestavia Hills AL, US
April Ellis - Pinson AL, US
Thomas P. Dooley - Pinson AL, US
Maria Belousova - Birmingham AL, US
Assignee:
Agenta Biotechnologies Inc. - Birmingham AL
International Classification:
A61K 39/00
C08B 37/08
A61K 47/36
A61K 31/7088
A61K 31/722
US Classification:
4241841, 514 44 R, 514 55, 514777, 536 20
Abstract:
A composition of exceptionally dense chitosan and a novel method for producing the dense chitosan structure have been described. The novel production method employs coincident compression and vacuum on a neutralized chitosan polymer that results in an exceptionally dense chitosan film or membrane material. The dense chitosan film or membrane composition possesses multiple physical and clinically appealing qualities for a variety of medical applications on or in animals, mammals, or humans.

Wound And Cutaneous Injury Healing With A Nucleic Acid Encoding Perlecan

View page
US Patent:
7141551, Nov 28, 2006
Filed:
Apr 22, 2003
Appl. No.:
10/420270
Inventors:
Arthur A. DeCarlo - Weston FL, US
John Whitelock - Homebush 2140, Sydney, AU
International Classification:
A61K 31/70
A01N 63/00
US Classification:
514 44, 424 932, 424450
Abstract:
A description of a biomolecule named Perlecan which is added internally or topically, or is expressed from exogenously added nucleic acids, as a whole or in part, to a healing wound to improve the success of wound healing is disclosed. Relevant embodiments for this patent technology are described.

Wikipedia

Art DeCarlo

View page

Arthur Anthony DeCarlo, Jr. (born March 23, 1931 in Youngstown, Ohio) is a former American football defensive back and end in the National Football League for the Pittsburgh Steelers ...

Isbn (Books And Publications)

Fumbled Kidnap

View page
Author

Arthur Decarlo

ISBN #

0759671788

Arthur A Decarlo from Vestavia, AL, age ~65 Get Report